NATHBIOGEN — Nath Bio-Genes (I) Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹4.69bn
- IN₹3.39bn
- IN₹3.33bn
- 50
- 73
- 64
- 72
Annual cashflow statement for Nath Bio-Genes (I), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 485 | 568 | -634 | 362 | 416 |
| Depreciation | |||||
| Non-Cash Items | 55.4 | 69.8 | 983 | 99.3 | 61.6 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -460 | -654 | -210 | -107 | 295 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 94.7 | 11.1 | 170 | 384 | 805 |
| Capital Expenditures | -162 | -38.6 | -11.2 | -25.5 | -83.9 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 17.7 | -64.2 | -187 | -3.35 | -190 |
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -144 | -103 | -199 | -28.8 | -274 |
| Financing Cash Flow Items | -65.5 | -88.2 | -106 | -101 | -91.1 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 55.6 | 164 | -222 | -16.7 | -137 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 6.01 | 72.3 | -250 | 338 | 394 |